A Randomized, Double-Blind, Placebo-Controlled and Open-Label Twelve Month Study of the Safety of (S)-Zopiclone in Adult Subjects With Insomnia
Latest Information Update: 11 Aug 2023
At a glance
- Drugs Eszopiclone (Primary)
- Indications Insomnia
- Focus Adverse reactions; Therapeutic Use
- Sponsors Sumitomo Pharma America
- 28 Apr 2015 New trial record